<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="drug-table.xslt"?><drug name = "risedronate tab">
<dose><value>35</value>
</dose>
<route><value>PO</value>
</route>
<strength><value>35 mg</value>
</strength>
<frequency><value>WEEKLY</value>
</frequency>
<instruction><value>Administer 30 minutes before breakfast.</value>
</instruction>
<volume></volume>
<units><value>mg</value>
</units>
<Population><value>ADULT</value>
</Population>
<IndicationPRN></IndicationPRN>
<AdditionalNotes><value>The benefits of bisphosphonate drugs in preventing fractures associated with osteoporosis outweigh the risk of an atypical femur fracture (Health Canada; December 19, 2011)</value>
</AdditionalNotes>
<BackgroundInformation></BackgroundInformation>
<PRNInformation></PRNInformation>
<AHSFormularyStatus><value>Formulary.</value>
</AHSFormularyStatus>
<AHFSName><value>Bone Resorption Inhibitors</value>
</AHFSName>
<HighAlert></HighAlert>
</drug>